Activation of Src-family tyrosine kinases in hyperproliferative epidermal disorders

Journal of Cutaneous Pathology

Volumn 35, Issue 3, 2008, Pages 273-277

  Ayli, Elias E ^a   Li, Weijie ^a   Brown, Tamu T ^a   Witkiewicz, Agnieszka ^a   Elenitsas, Rosalie ^a   Seykora, John T ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE;

ACTINIC KERATOSIS; ARTICLE; CARCINOMA IN SITU; CLINICAL ARTICLE; HUMAN; IMMUNOHISTOCHEMISTRY; PSORIASIS; SKIN BIOPSY; SKIN TUMOR; SQUAMOUS CELL CARCINOMA;

CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; EPIDERMIS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOENZYME TECHNIQUES; PHOTOSENSITIVITY DISORDERS; PSORIASIS; SKIN NEOPLASMS; SRC-FAMILY KINASES; TUMOR MARKERS, BIOLOGICAL;

EID: 38649140157     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2007.00807.x     Document Type: Article

References (15)

1. Schon MP, Boehncke WH. Psoriasis. N Engl J Med 2005 352 : 1899.
2. Jorissen RN, Walker F, Pouliot N, Garrett TP, Ward CW, Burgess AW. Epidermal growth factor receptor: mechanisms of activation and signalling. Exp Cell Res 2003 284 : 31.
3. Abram CL, Courtneidge SA. Src family tyrosine kinases and growth factor signaling. Exp Cell Res 2000 254 : 1.
4. Calautti E, Missero C, Stein PL, Ezzell RM, Dotto GP. Fyn tyrosine kinase is involved in keratinocyte differentiation control. Genes Dev 1995 9 : 2279.
5. Erpel T, Courtneidge SA. Src family protein tyrosine kinases and cellular signal transduction pathways. Curr Opin Cell Biol 1995 7 : 176.
6. Erkin G, Ugur Y, Gurer CK, et al. Effect of PUVA, narrow-band UVB and cyclosporin on inflammatory cells of the psoriatic plaque. J Cutan Pathol 2007 34 : 213.
7. Veale DJ, Barnes L, Rogers S, FitzGerald O. Immunohistochemical markers for arthritis in psoriasis. Ann Rheum Dis 1994 53 : 450.
8. Bieber T, Braun-Falco O. Distribution of CD1a-positive cells in psoriatic skin during the evolution of the lesions. Acta Derm Venereol 1989 69 : 175.
9. Zenz R, Eferl R, Kenner L, et al. Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 2005 437 : 369.
10. Sano S, Chan KS, Carbajal S, et al. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med 2005 11 : 43.
11. Matsumoto T, Jiang J, Kiguchi K, et al. Targeted expression of c-Src in epidermal basal cells leads to enhanced skin tumor promotion, malignant progression, and metastasis. Cancer Res 2003 63 : 4819.
12. Li W, Marshall C, Mei L, Gelfand J, Seykora JT. Srcasm corrects fyn-induced epidermal hyperplasia by kinase down-regulation. J Biol Chem 2007 282 : 1161.
13. Matsumoto T, Kiguchi K, Jiang J, et al. Development of transgenic mice that inducibly express an active form of c-Src in the epidermis. Mol Carcinog 2004 40 : 189.
14. Seykora JT, Mei L, Dotto GP, Stein PL. 'Srcasm: a novel Src activating and signaling molecule. J Biol Chem 2002 277 : 2812.
15. Li W, Marshall C, Mei L, et al. Srcasm modulates EGF and Src-kinase signaling in keratinocytes. J Biol Chem 2005 280 : 6036.